Shares of Medical Care Technologies Inc. (OTC: MDCE), a growing children’s healthcare service provider, jumped 35.29% to $0.0023, boosted by news the company has closed a $130 K loan agreement with a private Hong Kong company. The company said the proceeds are intended to be used for license completion and construction to operate its first children’s health and wellness center located in China. Over 29.96 million shares traded hands during the session, versus the 10-day average of 873 K.
Medinah Minerals Inc. (Pink: MDMN) rose 18.18% to $0.130, on above-average volume of 10.28 million shares. Over the past 52 weeks, the stock has ranged from a low of $0.04 to a high of $0.17. Medinah Minerals is a junior mining exploration company engages in the exploration and development of mineral properties primarily in South America.
Ecoland International Inc. (OTC: ECIT) spiked 108.04% to $0.233, on volume of 3.77 million shares. The stock has a 52-week range of $0.05 – $1.30. Ecoland International is a global provider of tube processing systems and technical solutions for the design, engineering and construction of automation-intensive projects.
Adarna Energy Corp. (OTC: ADRN) advanced 100.00% to $0.0002, on strong volume of 16.33 million shares. Adarna Energy, a technology development company, focuses on cleantech innovations designed to resolve ecological challenges while producing value added carbon neutral and negative products.
Vital Products Inc. (OTC: VTPI) gained 100.00% to $0.0004, on volume of over 477 K shares. Vital Products engages in the development, marketing, and distribution of eco-friendly industrial packaging products.
CoroWare Inc. (OTC: COWI) dipped 50.00% to $0.0001, with heavy volume of 48.31 million shares traded. The mobile service robot company earlier this month announced new software upgrades and hardware options for the CoroBot Classic and CoroBot Explorer product lines.
Guided Therapeutics Inc. (OTC: GTHP) hit a new 52-week low of $0.43, finishing the session down 51.01% to $0.73 on volume of 3.25 million shares. The company earlier today announced its submission of CE Mark approval application for its LuViva advanced cervical scan. Guided Therapeutics engages in the development of a rapid and painless testing platform for the early detection of disease based on its patented biophotonic technology that utilizes light to detect disease at the cellular level.
- Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
- See today’s top stock picks and market analysis
- Want more? Check out the message board buzz for these stocks
- See what newsletters are recommending these stock picks
- Get breaking news alerts on these stocks: http://thestockmarketwatch.com/
- This newsletter has been helping traders make a killing on these stocks. Click here for a 25% discount offer.
About BeaconEquity.com
BeaconEquity.com is committed to producing the highest-quality insight and analysis of small-cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily OTC stocks in the stock market today, which have traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.
Beacon Equity Group Disclaimer
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Beaconequity.com is a wholly-owned subsidiary of BlueWave Advisors.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
